Usage: ADZYNMA (ADAMTS13, recombinant-krhn) is indicated for prophylactic or on-demand enzyme replacement therapy in adults and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP).
Usage: ALUNBRIG is indicated for the treatment of adult patients with ALK-positive metastatic non-small cell lung cancer (NSCLC), confirmed by an FDA-approved test.
Usage: Carbatrol is indicated as an anticonvulsant for treating partial seizures (with complex symptoms), generalized tonic-clonic seizures, and mixed seizure patterns in epilepsy. Additionally, it is used to manage pain associated with true trigeminal neuralgia and has shown benefits in glossopharyngeal neuralgia. Not intended for trivial pain relief.